Fairfield Financial Advisors, LTD Iovance Biotherapeutics, Inc. Transaction History

Fairfield Financial Advisors, LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Nov 04, 2024	BUY	$5.53 - $8.22 $276 - $411	50 New	50 $308,000
Q3 2022 Oct 07, 2024	BUY	$9.53 - $13.11 $1,591 - $2,189	167 New	167 $1.6 Million
Q2 2022 Oct 07, 2024	BUY	$6.38 - $18.33 $1,065 - $3,061	167 New	167 $1.84 Million
Q1 2022 Oct 07, 2024	BUY	$12.38 - $19.1 $2,067 - $3,189	167 New	167 $2.78 Million

319

242M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $917M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Fairfield Financial Advisors, LTD, based on Form 13F filings with the SEC.

Stay updated on Fairfield Financial Advisors, LTD with notifications on news.